3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Leukemia, Myelomonocytic, Chronic
2
Breast Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oligodendroglioma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Extranodal NK-T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Hepatoblastoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
GATA2 Deficiency
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Brain Neoplasms
1
Interventions
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Etoposide
2
Cyclophosphamide
2
liposomal doxorubicin
1
fludarabine
1
dehydroftorafur
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
axicabtagene ciloleucel
1
Zidovudine
1
Vincristine
1
Valganciclovir
1
Standard of Care
1
Sirolimus
1
Sigmoidoscopy
1
Sentinel Lymph Node Biopsy
1
Rituximab
1
Raltegravir Potassium
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Prednisone
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Mitozytrex
1
Mitomycin
1
Melphalan
1
Interferon-alpha
1
Health Promotion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HIV Infections
×
Vorinostat
×
90 days
×
Clear all
No trials found.